用于健身的连续血糖监测设备因技术延迟和用户留存指标不佳而受到负面评价。
逐段跳播
血糖监测设备的问题在于存在15分钟的延迟。所以，我之前看了下应用，对自己说：“天哪，我感觉低血糖了。”然后她低头一看，说：“它告诉我我没事。”15分钟后读数突然下降，你会说：发生了什么？
我从中得到了什么好处？因此，我对用于健身的连续血糖监测设备有点悲观，因为它们反应慢。
The problem with glucose monitoring devices is that there is a 15-minute delay. So, I looked at the app earlier and said to myself, "Man, I'm feeling low blood sugar." Then she looks down and says, "He's telling me I'm okay." After 15 minutes the reading suddenly drops, and you say: What happened? What benefit did I gain from that? Therefore, I am a little pessimistic about continuous glucose monitoring devices for fitness because they are slow.
它反应慢的原因在于它实际上不在你的血液中，而是在你的肌肉里。它是一根扎入肌肉的针，试图捕捉细胞间的游离葡萄糖。葡萄糖从血液进入细胞间隙需要更长的时间，所以大约有15分钟的延迟。
The reason it's slow is that it's not actually in your blood, but in your muscles. It is a needle that goes into your muscles and tries to capture the free glucose between your cells. Glucose takes much longer to move from your blood into the spaces between your cells, so there is a delay of about 15 minutes.
在我看来，所有这些都导致使用率下降。我写过人们会对此感到厌倦。那么，截至6月30日，12个月付费订阅者的平均留存率为85%。这不是一件好事。嗯，你通常希望留存率是正的。如果你看日活跃用户与月活跃用户的比率，你会发现是65%。
这甚至更糟。在我看来，这意味着每100个人中，有65人实际上每天使用它。
All of this, in my opinion, leads to a decrease in usage. I wrote that people get bored of this. Well, as of June 30, the average 12-month paid subscriber retention rate was 85%. This is not a good thing. Well, you generally want a positive retention rate. If you look at the ratio of daily active users to monthly active users, you will find that it is 65%. And this is even worse. In my opinion, this means that out of every 100 people, 65 actually use it daily.
这里的数字可能被误解了。就让人工智能来核实我的信息吧。我不知道。他们发现了。但我的观点是，每天使用这个的人更少。这些东西只有每天使用才有效。所以，如果实际使用的人中大约三分之二每天使用，那就有问题。这将导致更多人厌倦使用这些产品并取消订阅。
The numbers here may have been misinterpreted. Just let artificial intelligence verify my information. I don't know. They found out. But my point is that there are fewer people who use this on a daily basis. These things only work if you use them daily. So, if about two-thirds of the people who actually use it are doing it daily, that's a problem. This will lead to more people becoming fed up with using these products and canceling their subscriptions.
根据我的经验，作为一个对技术非常感兴趣的人，我觉得准备好尝试这些东西。我对数据感兴趣。这不仅仅是收集数据。收集数据并据此采取行动对我有益。对我来说，坐着永远收集数据而不采取任何行动是没有益处的。
但一旦我根据数据采取行动，就没有太多可改变的了。如果我能从手表上获得心率变异性，反正我戴手表也是为了其他目的，那我就不需要这个了。
Based on my experience, and as someone who is very interested in technology, I feel ready to try these things. I am interested in data. It's not just about collecting data. It benefits me to collect data and act upon it. It is not beneficial for me to sit and collect data forever without doing anything. But once I act on the data, there isn't much left to change. If I can get the heart rate variance from my watch, which I wear anyway for other purposes, then I don't need this.
啊，所以我不知道。也许我对此悲观是出于错误的原因。谁知道呢？他们可能会定一个非常便宜的价格。总的来说，这些首次公开募股（IPO）通过设定低廉的价格来运作。所以，假设股票的市场价值在这里；他们故意压低价格以策划突然上涨。
这都是营销。但随后，经常有IPO失血，随着时间的推移进一步压低价格。我认为这次也不会有什么不同。
Ah, so I don't know. Perhaps I'm being pessimistic about this for the wrong reasons. Who knows? They might set a really cheap price. In general, these initial public offerings (IPOs) operate by setting inexpensive prices. So, let's say the market value of the stock is here; they are deliberately lowering the price to orchestrate a sudden rise. This is all marketing. But then, there are often IPO hemorrhages that drive the price down even further over time. I don't think this will be any different.
不幸的是，我对此有点悲观，也许我不应该这样，但这就是我对“Aura”的看法。
Unfortunately, I'm a bit pessimistic about this, and maybe I shouldn't be, but that's my opinion of "Aura".
这个频道对 $CGM 的历次判断
Meet Kevin 在这只股票上只有这一条判断。